🫀Low dose spironolactone is safe in ESRD, but monitor K+
🫀Spironolactone does not decrease CV events or HF hospitalizations in ESRD
🫀No meds (ACEi/statins) have improved CV mortality in ESRD to date; patiently awaiting SGLT2/GLP1/nsMRA studies in ESRD
🫀Low dose spironolactone is safe in ESRD, but monitor K+
🫀Spironolactone does not decrease CV events or HF hospitalizations in ESRD
🫀No meds (ACEi/statins) have improved CV mortality in ESRD to date; patiently awaiting SGLT2/GLP1/nsMRA studies in ESRD
💡PTH can increase as early as days after an AKI.
A 1978 study performed serial measurements of PTH in patients with AKI. They found that PTH was elevated within days of injury and returned to normal when renal function recovered.
https://buff.ly/3YKpgxx
💡PTH can increase as early as days after an AKI.
A 1978 study performed serial measurements of PTH in patients with AKI. They found that PTH was elevated within days of injury and returned to normal when renal function recovered.
https://buff.ly/3YKpgxx
I think MRAs in CKD are tricky to use.
You need a tight protocol - not a loosey-goosey pragmatic trial
I still remain a Spiro-stan, but the onus is on us to provide the good data
I think MRAs in CKD are tricky to use.
You need a tight protocol - not a loosey-goosey pragmatic trial
I still remain a Spiro-stan, but the onus is on us to provide the good data